Company Quick10K Filing
Nuzee
10-Q 2020-12-31 Filed 2021-02-12
10-K 2020-09-30 Filed 2020-12-28
10-Q 2020-06-30 Filed 2020-08-06
10-Q 2020-03-31 Filed 2020-05-07
10-Q 2019-12-31 Filed 2020-02-10
S-1 2019-11-12 Public Filing
10-K 2019-09-30 Filed 2019-12-26
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-15
10-Q 2018-12-31 Filed 2019-03-29
10-K 2018-09-30 Filed 2019-02-11
10-Q 2018-06-30 Filed 2018-08-16
10-Q 2018-03-31 Filed 2018-05-16
10-Q 2017-12-31 Filed 2018-04-06
10-K 2017-09-30 Filed 2018-02-21
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-19
10-Q 2016-12-31 Filed 2017-02-21
10-K 2016-09-30 Filed 2016-12-29
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-11
10-Q 2015-12-31 Filed 2016-02-16
10-K 2015-09-30 Filed 2016-01-13
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-18
10-Q 2014-12-31 Filed 2015-02-23
10-K 2014-09-30 Filed 2015-02-12
10-Q 2014-06-30 Filed 2014-08-19
10-Q 2014-03-31 Filed 2014-05-15
10-Q 2013-12-31 Filed 2014-02-12
10-K 2013-09-30 Filed 2014-01-14
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-01-31 Filed 2013-03-08
10-Q 2012-10-31 Filed 2012-12-14
10-K 2012-07-31 Filed 2012-10-29
10-Q 2012-04-30 Filed 2012-07-09
8-K 2020-11-18
8-K 2020-10-26
8-K 2020-09-28
8-K 2020-08-28
8-K 2020-07-10
8-K 2020-06-23
8-K 2020-06-18
8-K 2020-01-09
8-K 2019-10-22
8-K 2019-10-15
8-K 2019-08-28
8-K 2019-07-30
8-K 2019-05-09
8-K 2019-05-07
8-K 2019-01-23
8-K 2018-12-09
8-K 2018-08-31
8-K 2018-07-02
8-K 2018-06-27

Nuzee Financials

NUZE Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
1st Franklin Financial (FFC) 3,551 -0.6 7% 905,107 644,730 0 0 62,078 80,004 -45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200,033 7.9 1% 6,691,070 5,858,028 0 0 70,061 136,342 1,072,548
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 1,849 0 0 -1,663 -1,654 250
21Vianet Group (VNET) 6,005,116 0% 11,150,717 5,787,533 0 0 0 0 3,344,095
22nd Century (XXII) 301,854 1% -14.1 -36% 61,864 6,554 25,706 304 -22,433 -21,464 301,826
1Life Healthcare (ONEM)

Balance Sheet ($'000)2012-04-302012-07-312012-10-312013-01-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash5033751,111687796468238139282202108475717411631522925156161,8072,4421,1503,0611,326
Accounts Receivable332113024513018141214582012148517714114510791358540
Inventory655184107209202181237214206411361300302368135285277290501
PP&E291010113332421141921841741631522982802615575756747341,7261,9881,876
Assets533333301,2897959036483973045477225414495014215221,2341,2341,3841,8182,0532,9833,8283,5106,0575,251
Accounts Payable585660299843382015066785059189196295206135141268319702570341
Long-Term Debt167165147889190264157
Liabilities162112251201156018311552476287506666788177069451,1577714724304205705969319841,135
Stockholders' Equity-1212-9-222101,174735720534345257-80-28-125-229-316-285-423774639121,3871,6332,3193,1462,4264,9254,012
Income Statement ($'000)2012-04-302012-07-312012-10-312013-01-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue48170591241163029-44-51136224578376357391271353366585489
Cost of Revenue457700563365238-29-3073276417326239287173210245469575
Gross Profit3-600039510720-15-2164-521615111810398144121116-86
R&D
SG&A0020
Tax0000000100011000001
Net Income-8-1-21-13-297-355-1,403-656-618-459-302-407-363-397310338-325-303-346-385-644-737-640-2,577-1,434-9,3941,229
Cash Flow ($'000)2012-04-302012-07-312012-10-312013-01-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-511-321-422-361-494-427-286-501-404-257-263-286-363-237-352-328-513-716-599-743-569-1,638-1,451
Cash Investing-30-10-7-2-2-24-79-145-3-00-2160-38-294-60-126-956-139-818
Cash Financing7-1533367461,3634701682221876564033082052963232625123054961,2237721,4851883,749583